Literature DB >> 24332520

Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system.

Morten Schiodt1, Jesper Reibel2, Peter Oturai3, Thomas Kofod4.   

Abstract

OBJECTIVE: Nonexposed osteonecrosis of the jaws (NE-ONJ) does not fit into the current definition of osteonecrosis, which requires exposed bone. A modification of the classification of bisphosphonate-induced osteonecrosis of the jaws (ONJ) is proposed. This study aimed to test proposed criteria for NE-ONJ and compare NE-ONJ with exposed ONJ (E-ONJ) in a retrospective analysis. STUDY
DESIGN: In 102 patients with E-ONJ diagnosed according to Ruggiero et al. (2006, 2009), criteria for NE-ONJ were developed. Subgroups of NE-ONJ and E-ONJ were tested against each other using nonparametric and parametric statistics.
RESULTS: Among 102 patients with ONJ, 14 had NE-ONJ and 88 had E-ONJ. NE-ONJ and E-ONJ were similar in all important data (P > .05) except bone exposure.
CONCLUSIONS: NE-ONJ belongs to the same disease condition as E-ONJ. NE-ONJ may be otherwise classified as ONJ stage 1, 2, or 3 and is different from ONJ stage 0. We propose to include the criteria for NE-ONJ into the classification.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24332520     DOI: 10.1016/j.oooo.2013.10.010

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  31 in total

Review 1.  Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.

Authors:  Valesca Sander Koth; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2016-05-31       Impact factor: 2.419

Review 2.  Adjudication of osteonecrosis of the jaw in phase III randomized controlled trials of denosumab: a systematic review.

Authors:  Paul de Boissieu; L Kanagaratnam; R Mahmoudi; A Morel; M Dramé; T Trenque
Journal:  Eur J Clin Pharmacol       Date:  2017-02-10       Impact factor: 2.953

3.  Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.

Authors:  Akishige Hokugo; Keiichi Kanayama; Shuting Sun; Kenzo Morinaga; Yujie Sun; QingQing Wu; Hodaka Sasaki; Hiroko Okawa; Courtney Evans; Frank H Ebetino; Mark W Lundy; Keivan Sadrerafi; Charles E McKenna; Ichiro Nishimura
Journal:  Bone       Date:  2019-03-26       Impact factor: 4.398

4.  Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy.

Authors:  Valesca S Koth; Maria A Figueiredo; Fernanda G Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2017-02-17       Impact factor: 2.419

5.  Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.

Authors:  Sil Park; Keiichi Kanayama; Kawaljit Kaur; Han-Ching Helen Tseng; Sina Banankhah; Davood Talebi Quje; James W Sayre; Anahid Jewett; Ichiro Nishimura
Journal:  J Biol Chem       Date:  2015-05-26       Impact factor: 5.157

Review 6.  Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors.

Authors:  Jason T Wan; Douglas M Sheeley; Martha J Somerman; Janice S Lee
Journal:  Bone Res       Date:  2020-03-11       Impact factor: 13.567

7.  Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.

Authors:  Ourania Nicolatou-Galitis; Maria Kouri; Erofili Papadopoulou; Emmanouil Vardas; Dimitra Galiti; Joel B Epstein; Sharon Elad; Giuseppina Campisi; Nikolaos Tsoukalas; Kivanc Bektas-Kayhan; Winston Tan; Jean-Jacques Body; Cesar Migliorati; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2018-10-23       Impact factor: 3.603

Review 8.  Detecting the earliest radiological signs of bisphosphonate-related osteonecrosis.

Authors:  H Devlin; J Greenwall-Cohen; J Benton; T L Goodwin; A Littlewood; K Horner
Journal:  Br Dent J       Date:  2017-11-17       Impact factor: 1.626

9.  Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.

Authors:  P A Eiken; D Prieto-Alhambra; R Eastell; B Abrahamsen
Journal:  Osteoporos Int       Date:  2017-06-29       Impact factor: 4.507

10.  Use and Evaluation of a Computer-Assisted Examination Method for the Diagnosis and Analysis of Medication-Related Osteonecrosis of the Jaw.

Authors:  Max Wilkat; Daman Deep Singh; Isabelle Lutz; Henriette Möllmann; Nils-Claudius Gellrich; Majeed Rana
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2020-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.